MRVL vs SPRY · P/E 100, rev $5.16B vs rev $56.3M
Marvell Technology Group Ltd (MRVL) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the MRVL and SPRY stock pages for the full models.
Not investment advice.